Novashunt renamed Sequana as firm gears up for ALFApump Q3 launch
This article was originally published in Clinica
NovaShunt, a specialist in automated implantable fluid removal systems, is now trading under the name Sequana Medical. The Zug, Switzerland firm said it wanted to ensure that the new company name was clearly differentiated from the names of its products. Sequana’s first product is ALFApump, an automated low-flow ascites (ALFA) pump system. The battery-powered device is implanted subcutaneously and removes ascites – excess abdominal fluid associated with liver cirrhosis, certain cancers and congestive heart failure – by transferring it to the bladder where it is eliminated through normal urination.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.